Health Regulation

Product Safety FDA Medical Oversight Public Health Agencies Consumer Safety Healthcare Oversight Drug Approval Food and Drug Administration Pharmaceutical Oversight

Novartis Says Two Children's Tumours Show Evidence Linked to Zolgensma

Evidence that the treatment's viral carrier may have inserted genes into patients' DNA raises new safety concerns, triggering regulatory reviews

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent and Metastatic HNSCC

Samsung Wins South Korean Approval for Hearing Test and Hearing‑Aid Features on Galaxy Buds

Samsung Rolls Out Graded Sleep-Apnea Screening to Galaxy Ring and Watches

FDA Grants Accelerated Approval to Voceryq, First Plasmid DNA Immunotherapy

Samsung Adds AI Sleep-Apnea Tiers to Galaxy Ring and Watches

Apple Enables AirPods Pro Hearing Tools in Five Canadian Provinces

Capricor Seeks New FDA Path for Duchenne Drug After 9–3 Advisory Vote

Anvisa Orders Seizure and Nationwide Ban on Six Salt Brands

Mexico Makes Digital Health Mandatory, But Systems and Funding Lag

Court Orders Nine Months' Preventive Detention for Two Doctors in Death of 7‑Year‑Old

Health Canada Stands By No-Link Finding After Two Winnipeg Plasma Donor Deaths

Embryo Donors Sue Monash IVF Over Brisbane Mix-Up

Ju Massaoka Says PMMA Was Found in Her Nose After Prior Rhinoplasty Without Consent

Piura Raids Seize 879 Suspect Medicines, Shut Down Informal Pharmacy

SAHPRA Orders Withdrawal and Reclassification of Children's Zinc and Selenium Products

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

Doctors and Pharmacists Demand Crackdown on Telehealth Cannabis Prescribing as AHPRA Tightens Rules

Monash IVF Review Finds Human Error as Company Keeps Report Secret

ANMAT Prohibits Dutaflox Duo Lot B461 and Illicit Health and Beauty Products